Modulation of hypoxia-inducible factor-1α expression by mitochondrial NADP+-dependent isocitrate dehydrogenase

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 28, Issue SUPPL. 3, 2010, Pages 1908-1913

  Kim, Sung Youl ^a   Park, Jeen Woo ^a  

^a Kyungpook National University   (South Korea)

Author keywords

HIF 1 ; IDPm; PI3K Akt; SiRNA

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CYCLOHEXIMIDE; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; ISOCITRATE DEHYDROGENASE (NADP); PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SP1; VASCULOTROPIN; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; MALE; OXIDATION REDUCTION REACTION; PROSTATE CANCER; PROTEIN EXPRESSION; RNA INTERFERENCE; CANCER CELL; GENETIC TRANSFECTION; HYPOXIA; TRANSCRIPTION TERMINATION;

ACETYLCYSTEINE; CELL LINE, TUMOR; CYCLOHEXIMIDE; CYSTEINE PROTEINASE INHIBITORS; FREE RADICAL SCAVENGERS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOBLOTTING; ISOCITRATE DEHYDROGENASE; LEUPEPTINS; MITOCHONDRIAL PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN SYNTHESIS INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SP1 TRANSCRIPTION FACTOR;

EID: 78650236478     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.biochi.2010.08.004     Document Type: Article

References (32)

1. G. Melillo HIF-1: a target for cancer, ischemia and inflammation-too good to be true? Cell Cycle 3 2004 154 155
2. G.L. Semenza Targeting HIF-1 for cancer therapy Nat. Rev. Cancer 3 2003 721 732
3. 2 tensionm Proc. Natl. Acad. Sci. USA 92 1995 5510 5514
4. 2 tension Am. J. Physiol. 271 1996 C1172 C1180
5. 2 homeostasis by hypoxia-inducible factor 1 Annu. Rev. Cell. Dev. Biol. 15 1999 551 578
6. F. Li, P. Sonveaux, Z.N. Rabbani, S. Liu, B. Yan, Q. Huang, Z. Vujaskovic, M.W. Dewhirst, and C.Y. Li Regulation of HIF-1α stability through S-nitrosylation Mol. Cell. 26 2007 63 74
7. M. Kilic, H. Kasperczyk, S. Fulda, and K.M. Debatin Role of hypoxia inducible factor-1α in modulation of apoptosis resistance Oncogene 26 2007 2027 2038
8. Z. Dong, J.Z. Wang, F. Yu, and M.A. Venkatachalam Apoptosis-resistance of hypoxic cells: multiple factors involved and a role for IAP-2 Am. J. Pathol. 163 2003 663 671
9. X.H. Pang, P. Karna, Z. Cao, B.H. Jiang, M. Zhou, and L. Yang Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1α signal pathways increases resistance to apoptosis by up-regulating survivin gene expression J. Biol. Chem. 281 2006 25903 25914
10. D.E. Koshland, K. Walsh, and D.C. LaPorte Sensitivity of metabolic fluxes to covalent control Curr. Top. Cell. Regul. 27 1985 13 22
11. M. Kirsch, and H. de Groot NAD(P)H, a directly operating antioxidant? FASEB J. 15 2001 1569 1574
12. H. Nakamura Thioredoxin and its related molecules: update 2005 Antioxid. Redox Signal. 7 2005 823 828
13. +-dependent isocitrate dehydrogenase J. Biol. Chem. 276 2001 16168 16176
14. +-dependent isocitrate dehydrogenase J. Biol. Chem. 282 2007 13385 13394
15. +-dependent isocitrate dehydrogenase enhances the sensitivity of HeLa cells toward tumor necrosis factor-a and anticancer drugs Free Radic. Biol. Med. 43 2007 1197 1207
16. S. Zhao, Y. lin, W. Xu, W. Jiang, Z. Zha, P. Wang, W. Yu, Z. Li, L. Gong, Y. Peng, J. Ding, Q. Lei, K.L. Guan, and Y. Xiong Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1α Science 324 2009 261 265
17. T.L. Huh, J.H. Ryu, J.W. Huh, H.C. Sung, I.U. Oh, B.J. Song, and R.L. Veech Cloning of a cDNA encoding bovine mitochondrial NADP(+)-specific isocitrate dehydrogenase and structural comparison with its isoenzymes from different species Biochem. J. 292 1993 705 710
18. I.U. Oh, J. Inazawa, Y.O. Kim, B.J. Song, and T.L. Huh Assignment of the human mitochondrial NADP(+)-specific isocitrate dehydrogenase (IDH2) gene to 15q26.1 by in situ hybridization Genomics 38 1996 104 106
19. G.W.E. Plaut, M. Cook, and T. Aogaichi The subcellular location of isozymes of NADP-isocitrate dehydrogenase in tissues from pig, ox and rat Biochim. Biophys. Acta 760 1983 300 308
20. N.V. Iyer, S.W. Leung, and G.L. Semenza The human hypoxia-inducible factor 1α gene: HIF1A structure and evolutionary conservation Genomics 52 1998 159 165
21. A.R. Black, J.D. Black, and J. Azizkjan-Clifford Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer J. Cell. Physiol. 188 2001 143 160
22. Q. Shi, X. Le, J.L. Abbruzzese, Z. Peng, C.N. Qian, H. Tang, Q. Xiong, B. Wang, X.C. Li, and K. Xie Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma Cancer Res. 61 2001 4143 4154
23. N. Pore, S. Liu, H.K. Shu, D. Haas-Kogan, D. Stokoe, J. Milanini-Monigiat, G. Pages, D.M. O'Rourke, E. Bernhard, and A. Maity Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism Mol. Biol. Cell 15 2004 4841 4853
24. I.N. Zelko, and R.J. Folz Sp1 and Sp3 transcription factors mediate trichostatin A-induced and basal expression of extracellular superoxide dismutase Free Radic. Biol. Med. 37 2004 1256 1271
25. J.E. Thompson, and C.B. Thompson Putting the rap on Akt J. Clin. Oncol. 22 2004 4217 4226
26. B.H. Jiang, G. Jiang, J.Z. Zheng, Z. Lu, T. Hunter, and P.K. Vogt Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1 Cell Growth Differ. 12 2001 363 369
27. D.R. Alessi, S.R. James, C.P. Downes, A.B. Holmes, P.R. Gaffney, C.B. Reese, and P. Cohen Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα Curr. Biol. 7 1997 261 269
28. R.D. Guzy, and P.T. Schumacker Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia Exp. Physiol. 91 2006 807 819
29. S. Guo, M. Miyake, K.J. Liu, and H. Shi Specific inhibition of hypoxia inducible factor I exaggerates cell injury induced by in vitro ischemia through deteriorating cellular redox environment J. Neurochem. 108 2009 1309 1321
30. E.D. MacKenzie, M.A. Selak, D.A. Tennant, L.J. Payne, S. Crosby, C.M. Frederiksen, D.G. Watson, and E. Gottlieb Cell-permeating α-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells Mol. Cell. Biol. 27 2007 3282 3289
31. H. Zhong, K. Chiles, D. Feldser, E. Laughner, C. Hanrahan, M.M. Georgescu, J.W. Simons, G.L. Semenza, and J.W. Simons Modulation of hypoxia-inducible factor 1a expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics Cancer Res. 60 2000 1541 1545
32. H. Zhong, K. Chiles, D. Feldser, E. Laughner, C. Hanrahan, M.M. Georgescu, J.W. Simons, G.L. Semenza, and J.W. Simons Overexpression of hypoxia-inducible factor 1a in common human cancers and their metastases Cancer Res. 59 1999 5830 5835